What Details? A Lack of Transparency Impedes Access to Medicines

The lack of affordable prescription medicines is a global problem. But even as various governments, nonprofit organizations and pharmaceutical companies attempt to address the issue, agreements lack transparency. The absence of key details - notably, pricing, in some instances - makes it difficult to determine whether the deals will sufficiently succeed in providing needed medicines.

Authors

Publication Details

Journal
The Journal of Law Medicine & Ethics
Published
2026-11-06
DOI
https://doi.org/10.1017/jme.2026.10300
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What Details? A Lack of Transparency Impedes Access to Medicines

Ed Silverman
The Journal of Law Medicine & Ethics
Pharmaceutical Economics and Policy
article

What Details? A Lack of Transparency Impedes Access to Medicines

Ed Silverman
article en

Abstract

The lack of affordable prescription medicines is a global problem. But even as various governments, nonprofit organizations and pharmaceutical companies attempt to address the issue, agreements lack transparency. The absence of key details - notably, pricing, in some instances - makes it difficult to determine whether the deals will sufficiently succeed in providing needed medicines.

The Journal of Law Medicine & Ethics
Openalex Percentile: Top 11%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What Details? A Lack of Transparency Impedes Access to Medicines — Ed Silverman · The Journal of Law Medicine & Ethics (2026) | TGRS Research Map | TGRS